Studies conducted on our cohort of patients demonstrated that determination of MMP-9 could be useful as a possible supportive marker permitting differentiation between active and inactive forms of IBD as well as between active UC and active CD. This evidence concerns the gene MMP9 and inflammatory bowel disease.